Click to enlarge
Previous product
Bavencio (avelumab) CHF1,098.58
Back to products
Next product
Cotellic (cobimetinib) CHF6,355.34

Cometriq (cabozantinib)

CHF6,222.09

Cometriq (cabozantinib) is a medication used for the treatment of progressive, metastatic medullary thyroid cancer (MTC).

Compare
Add to wishlist
Category:
Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Cometriq (cabozantinib)”

Your email address will not be published.

Related products

Compare
Quick view
Add to wishlist
Add to cart
Close

Tivdak (tisotumab vedotin-tftv)

CHF8,378.37
Compare
Quick view
Add to wishlist
Add to cart
Close

Rybrevant (amivantamab-vmjw)

CHF7,507.36
Compare
Quick view
Add to wishlist
Add to cart
Close

Pemazyre (pemigatinib)

CHF38,050.29
Compare
Quick view
Add to wishlist
Add to cart
Close

Xalkori (crizotinib)

CHF4,927.62
Compare
Quick view
Add to wishlist
Add to cart
Close

Zepzelca (lurbinectedin)

CHF12,956.62
Compare
Quick view
Add to wishlist
Add to cart
Close

Trodelvy (sacituzumab govitecan-hziy)

CHF4,685.80
Compare
Quick view
Add to wishlist
Add to cart
Close

Monjuvi (tafasitamab-cxix)

CHF4,160.00
Compare
Quick view
Add to wishlist
Add to cart
Close

Danyelza (naxitamab-gqgk)

CHF35,282.47